AKT1 and neoplasm: Amplification of FGFR leads to enhanced activation of downstream signaling pathways (such as phospholipase Cγ (PLCγ), PI3K–AKT, Ras–Raf–MAPK, and STATs), resulting in an increased sensitivity to FGF and the promotion of tumor growth [32].